Schrödinger, Inc. (SDGR) 10-Year Financial Performance & Capital Metrics

SDGR • • Industrial / General

HealthcareHealthcare ITLife Sciences TechnologyDrug Discovery & Development

AboutSchrödinger, Inc., together with its subsidiaries, provides physics-based software platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on selling its software for drug discovery in the life sciences industry, as well as to customers in materials science industries. The Drug Discovery segment focuses on building a portfolio of preclinical and clinical programs, internally and through collaborations. The company serves biopharmaceutical and industrial companies, academic institutions, and government laboratories worldwide. Schrödinger, Inc. was incorporated in 1990 and is based in New York, New York.Show more

Revenue $208M -4.2%
EBITDA -$203M -18.2%
Net Income -$187M -559.5%
EPS (Diluted) -2.57 -575.9%
Gross Margin 63.64% -2.0%
EBITDA Margin -97.88% -23.4%
Operating Margin -100.85% -23.1%
Net Margin -90.16% -579.7%
ROE -38.58% -572.1%
ROIC -34.38% -28.5%
Debt/Equity 0.28 +19.9%
Interest Coverage -

Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

✓Strong 5Y sales CAGR of 19.4%
✓Share count reduced 3.1% through buybacks

✗Weaknesses

✗Weak Piotroski F-Score: 3/9
✗Negative free cash flow
✗Trading more than 30% below 52-week high
✗Low asset turnover indicates capital-intensive operations

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y-

5Y19.39%

3Y14.59%

TTM32.9%

Profit (Net Income) CAGR

10Y-

5Y-

3Y-

TTM0.89%

EPS CAGR

10Y-

5Y-

3Y-

TTM1.63%

ROCE

10Y Avg-30.43%

5Y Avg-23.28%

3Y Avg-28.06%

Latest-32.18%

Peer Comparison

Drug Discovery & Development

Name	Market Cap	Current Price	P/E Ratio	Revenue Growth 1Y	Net Margin	ROE	FCF Yield	Debt/Equity
SLPSimulations Plus, Inc.	408.17M	20.26	-6.29	13.09%	-81.66%	-50.54%	4.27%	0.00
SDGRSchrödinger, Inc.	1.13B	17.47	-6.80	-4.21%	-68.49%	-54.77%		0.28
CERTCertara, Inc.	1.52B	9.52	-126.76	8.7%	2.62%	1.02%	5.2%	0.29

Profit & Loss

	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Sales/Revenue+	55.69M	66.64M	85.54M	108.09M	137.93M	180.96M	216.67M	207.54M
Revenue Growth %	-	0.2%	0.28%	0.26%	0.28%	0.31%	0.2%	-0.04%
Cost of Goods Sold+	15.89M	23.7M	36.45M	44.62M	72.31M	79.93M	75.97M	75.46M
COGS % of Revenue	0.29%	0.36%	0.43%	0.41%	0.52%	0.44%	0.35%	0.36%
Gross Profit+	39.8M	42.94M	49.09M	63.47M	65.62M	101.02M	140.69M	132.08M
Gross Margin %	0.71%	0.64%	0.57%	0.59%	0.48%	0.56%	0.65%	0.64%
Gross Profit Growth %	-	0.08%	0.14%	0.29%	0.03%	0.54%	0.39%	-0.06%
Operating Expenses+	58.82M	70.91M	87.81M	124.39M	177.06M	247.84M	318.14M	341.38M
OpEx % of Revenue	1.06%	1.06%	1.03%	1.15%	1.28%	1.37%	1.47%	1.64%
Selling, General & Admin	31.15M	36.38M	48.4M	59.69M	86.16M	121.47M	136.37M	139.59M
SG&A % of Revenue	0.56%	0.55%	0.57%	0.55%	0.62%	0.67%	0.63%	0.67%
Research & Development	27.67M	34.52M	39.4M	64.69M	90.9M	126.37M	181.77M	201.78M
R&D % of Revenue	0.5%	0.52%	0.46%	0.6%	0.66%	0.7%	0.84%	0.97%
Other Operating Expenses	0	0	0	0	0	0	0	0
Operating Income+	-19.02M	-27.97M	-38.72M	-60.92M	-111.44M	-146.82M	-177.45M	-209.3M
Operating Margin %	-0.34%	-0.42%	-0.45%	-0.56%	-0.81%	-0.81%	-0.82%	-1.01%
Operating Income Growth %	-	-0.47%	-0.38%	-0.57%	-0.83%	-0.32%	-0.21%	-0.18%
EBITDA+	-17.34M	-25.07M	-35.08M	-57.26M	-108.6M	-142.47M	-171.9M	-203.14M
EBITDA Margin %	-0.31%	-0.38%	-0.41%	-0.53%	-0.79%	-0.79%	-0.79%	-0.98%
EBITDA Growth %	-	-0.45%	-0.4%	-0.63%	-0.9%	-0.31%	-0.21%	-0.18%
D&A (Non-Cash Add-back)	1.69M	2.89M	3.64M	3.66M	2.85M	4.34M	5.55M	6.16M
EBIT	-19.02M	-27.97M	-38.72M	-60.92M	-111.44M	-146.82M	-177.45M	-209.3M
Net Interest Income+	359K	433K	1.88M	2.25M	1.06M	3.95M	0	0
Interest Income	359K	433K	1.88M	2.25M	1.06M	3.95M	0	0
Interest Expense	0	0	0	0	0	3K	0	0
Other Income/Expense	1.96M	-379K	12.74M	34.62M	10.63M	-2.31M	220.37M	23.59M
Pretax Income+	-17.06M	-28.35M	-25.97M	-26.29M	-100.81M	-149.12M	42.92M	-185.71M
Pretax Margin %	-0.31%	-0.43%	-0.3%	-0.24%	-0.73%	-0.82%	0.2%	-0.89%
Income Tax+	332K	77K	-291K	345K	411K	63K	2.2M	1.41M
Effective Tax Rate %	1.02%	1%	0.95%	0.93%	1%	1%	0.95%	1.01%
Net Income+	-17.39M	-28.43M	-24.57M	-24.46M	-100.39M	-149.19M	40.72M	-187.12M
Net Margin %	-0.31%	-0.43%	-0.29%	-0.23%	-0.73%	-0.82%	0.19%	-0.9%
Net Income Growth %	-	-0.63%	0.14%	0%	-3.1%	-0.49%	1.27%	-5.6%
Net Income (Continuing)	-17.39M	-28.43M	-25.68M	-26.64M	-101.22M	-149.19M	40.72M	-187.12M
Discontinued Operations	0	0	0	0	0	0	0	0
Minority Interest	0	0	41K	4K	14K	11K	0	0
EPS (Diluted)+	-3.07	-0.59	-0.41	-0.44	-1.43	-2.10	0.54	-2.57
EPS Growth %	-	0.81%	0.31%	-0.07%	-2.25%	-0.47%	1.26%	-5.76%
EPS (Basic)	-3.07	-0.59	-0.41	-0.44	-1.43	-2.10	0.57	-2.57
Diluted Shares Outstanding	5.67M	48.47M	63.27M	60.02M	70.59M	71.17M	74.99M	72.67M
Basic Shares Outstanding	5.67M	48.47M	63.27M	60.02M	70.59M	71.17M	71.78M	72.67M
Dividend Payout Ratio	-	-	-	-	-	-	-	-

Balance Sheet

	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Current Assets+	48.05M	104.69M	118.54M	682.98M	625.06M	533.99M	567.8M	634.99M
Cash & Short-Term Investments	36.34M	84.07M	85.83M	642.69M	576.48M	451.09M	463M	352.12M
Cash Only	9.96M	77.72M	25.99M	202.3M	120.27M	90.47M	155.31M	147.33M
Short-Term Investments	26.38M	6.35M	59.84M	440.39M	456.21M	360.61M	307.69M	204.8M
Accounts Receivable	9.76M	18.02M	25.74M	35.38M	40.55M	69.09M	89.12M	255.33M
Days Sales Outstanding	63.96	98.71	109.82	119.46	107.31	139.36	150.13	449.06
Inventory	0	0	0	0	0	0	0	0
Days Inventory Outstanding	-	-	-	-	-	-	-	-
Other Current Assets	0	0	500K	500K	3M	5.24M	5.75M	15.33M
Total Non-Current Assets+	9.97M	16.04M	36.73M	63.28M	131.43M	154.6M	235.16M	188.23M
Property, Plant & Equipment	5.44M	7.97M	19.03M	15.27M	85.41M	120.23M	141.1M	136.08M
Fixed Asset Turnover	10.24x	8.36x	4.50x	7.08x	1.61x	1.51x	1.54x	1.53x
Goodwill	0	0	0	0	0	4.79M	4.79M	4.79M
Intangible Assets	52K	15K	0	0	0	587K	0	0
Long-Term Investments	2.61M	5.44M	15.37M	45.66M	43.17M	25.68M	83.25M	43.21M
Other Non-Current Assets	1.87M	2.61M	2.34M	2.35M	2.85M	3.31M	6.01M	4.16M
Total Assets+	58.02M	120.73M	155.27M	746.26M	756.49M	688.59M	802.96M	823.23M
Asset Turnover	0.96x	0.55x	0.55x	0.14x	0.18x	0.26x	0.27x	0.25x
Asset Growth %	-	1.08%	0.29%	3.81%	0.01%	-0.09%	0.17%	0.03%
Total Current Liabilities+	17.82M	27M	45.02M	73.2M	91.21M	108.8M	133.67M	191.75M
Accounts Payable	1.61M	2.77M	3.52M	8.4M	8.08M	9.47M	16.82M	10.67M
Days Payables Outstanding	36.98	42.7	35.29	68.69	40.78	43.24	80.78	51.59
Short-Term Debt	0	0	0	0	0	0	0	0
Deferred Revenue (Current)	1000K	1000K	1000K	1000K	1000K	1000K	1000K	1000K
Other Current Liabilities	2.41M	0	0	0	0	0	0	0
Current Ratio	2.70x	3.88x	2.63x	9.33x	6.85x	4.91x	4.25x	3.31x
Quick Ratio	2.70x	3.88x	2.63x	9.33x	6.85x	4.91x	4.25x	3.31x
Cash Conversion Cycle	-	-	-	-	-	-	-	-
Total Non-Current Liabilities+	85.57M	165.28M	203.57M	49.04M	108.19M	131.88M	120.72M	210.03M
Long-Term Debt	0	0	0	0	0	0	0	0
Capital Lease Obligations	0	0	8.89M	7.22M	77.83M	105.48M	111.01M	101.07M
Deferred Tax Liabilities	0	0	0	0	0	0	0	0
Other Non-Current Liabilities	82.79M	162.17M	192.48M	654K	300K	800K	667K	146K
Total Liabilities	103.38M	192.29M	248.59M	122.24M	199.4M	240.68M	254.4M	401.78M
Total Debt+	0	0	14.47M	11.76M	79.87M	116.49M	127.88M	117.83M
Net Debt	-9.96M	-77.72M	-11.51M	-190.53M	-40.4M	26.02M	-27.43M	-29.5M
Debt / Equity	-	-	-	0.02x	0.14x	0.26x	0.23x	0.28x
Debt / EBITDA	-	-	-	-	-	-	-	-
Net Debt / EBITDA	-	-	-	-	-	-	-	-
Interest Coverage	-	-	-	-	-	-48939.00x	-	-
Total Equity+	-45.36M	-71.56M	-93.32M	624.02M	557.09M	447.9M	548.56M	421.44M
Equity Growth %	-	-0.58%	-0.3%	7.69%	-0.11%	-0.2%	0.22%	-0.23%
Book Value per Share	-8.00	-1.48	-1.48	10.40	7.89	6.29	7.32	5.80
Total Shareholders' Equity	-45.36M	-71.56M	-93.36M	624.01M	557.07M	447.89M	548.56M	421.44M
Common Stock	55K	59K	61K	699K	710K	714K	722K	729K
Retained Earnings	-52.1M	-80.53M	-105.1M	-129.56M	-229.95M	-379.14M	-338.42M	-525.54M
Treasury Stock	-6.36M	-8.53M	0	0	0	0	0	0
Accumulated OCI	-27K	-9K	16K	317K	-651K	-2.38M	281K	220K
Minority Interest	0	0	41K	4K	14K	11K	0	0

Cash Flow

	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Cash from Operations+	-15.31M	-23.71M	-26.06M	16.76M	-70.67M	-119.68M	-136.73M	-157.37M
Operating CF Margin %	-0.27%	-0.36%	-0.3%	0.16%	-0.51%	-0.66%	-0.63%	-0.76%
Operating CF Growth %	-	-0.55%	-0.1%	1.64%	-5.22%	-0.69%	-0.14%	-0.15%
Net Income	-17.39M	-28.43M	-25.68M	-26.64M	-101.22M	-149.19M	40.72M	-187.12M
Depreciation & Amortization	1.69M	2.89M	3.64M	3.66M	2.85M	4.34M	5.55M	6.16M
Stock-Based Compensation	888K	1.31M	2.19M	10.54M	26.49M	39.63M	47.84M	49.9M
Deferred Taxes	-2.1M	375K	0	-32.12M	0	0	0	0
Other Non-Cash Items	19K	-149K	-10.51M	2.14M	-3.46M	6.91M	-208.29M	-13.27M
Working Capital Changes	1.59M	281K	4.29M	59.18M	4.68M	-21.38M	-22.55M	-13.04M
Change in Receivables	-3.1M	-4.27M	-6.59M	-12.75M	-5.51M	-27.95M	-20.03M	-166.22M
Change in Inventory	2.65M	-3.86M	0	7.34M	0	0	0	0
Change in Payables	45K	969K	-294K	4.88M	-411K	1.18M	7.32M	-6.12M
Cash from Investing+	2.05M	11.19M	-53.85M	-381.72M	-16.81M	90.02M	193.03M	148.84M
Capital Expenditures	-3.7M	-5.26M	-1.84M	-2.54M	-7.17M	-8.01M	-13.4M	-7.31M
CapEx % of Revenue	0.07%	0.08%	0.02%	0.02%	0.05%	0.04%	0.06%	0.04%
Acquisitions	-	-	-	-	-	-	-	-
Investments	-	-	-	-	-	-	-	-
Other Investing	3.24M	-3.65M	943K	4.58M	375K	11.82M	147.21M	0
Cash from Financing+	1.13M	80.27M	28.68M	541.27M	7.95M	2.11M	9.05M	10.12M
Debt Issued (Net)	-	-	-	-	-	-	-	-
Equity Issued (Net)	-	-	-	-	-	-	-	-
Dividends Paid	0	0	0	0	0	0	0	0
Share Repurchases	-	-	-	-	-	-	-	-
Other Financing	0	80.27M	-1.21M	4.18M	7.95M	2.11M	9.07M	1.31M
Net Change in Cash	-	-	-	-	-	-	-	-
Free Cash Flow+	-19.01M	-28.97M	-27.89M	14.22M	-77.84M	-127.7M	-150.14M	-164.68M
FCF Margin %	-0.34%	-0.43%	-0.33%	0.13%	-0.56%	-0.71%	-0.69%	-0.79%
FCF Growth %	-	-0.52%	0.04%	1.51%	-6.47%	-0.64%	-0.18%	-0.1%
FCF per Share	-3.35	-0.60	-0.44	0.24	-1.10	-1.79	-2.00	-2.27
FCF Conversion (FCF/Net Income)	0.88x	0.83x	1.06x	-0.68x	0.70x	0.80x	-3.36x	0.84x
Interest Paid	0	0	0	0	0	0	0	0
Taxes Paid	348K	13K	139K	381K	448K	787K	2.83M	1.08M

Key Ratios

Metric	2017	2018	2019	2020	2021	2022	2023	2024
Return on Equity (ROE)	-	-	-	-9.22%	-17%	-29.69%	8.17%	-38.58%
Return on Invested Capital (ROIC)	-	-	-	-27.8%	-17.59%	-22.23%	-26.75%	-34.38%
Gross Margin	71.46%	64.43%	57.39%	58.72%	47.57%	55.83%	64.94%	63.64%
Net Margin	-31.23%	-42.66%	-28.72%	-22.63%	-72.78%	-82.44%	18.79%	-90.16%
Debt / Equity	-	-	-	0.02x	0.14x	0.26x	0.23x	0.28x
Interest Coverage	-	-	-	-	-	-48939.00x	-	-
FCF Conversion	0.88x	0.83x	1.06x	-0.68x	0.70x	0.80x	-3.36x	0.84x
Revenue Growth	-	19.65%	28.37%	26.36%	27.6%	31.19%	19.73%	-4.21%

Revenue by Segment

	2020	2021	2022	2023	2024
Software Products And Services	92.53M	113.24M	-	159.12M	180.37M
Software Products And Services Growth	-	22.38%	-	-	13.35%
Revenue From Contract With Customer Before Software Contribution	-	112.24M	-	157.32M	172.35M
Revenue From Contract With Customer Before Software Contribution Growth	-	-	-	-	9.55%
On Premise Software	58.31M	74.6M	-	104.51M	104.02M
On Premise Software Growth	-	27.93%	-	-	-0.47%
Hosted Software	9.19M	11.08M	-	20.38M	35.25M
Hosted Software Growth	-	20.50%	-	-	72.97%
Maintenance	14.46M	17.29M	-	23.07M	23.28M
Maintenance Growth	-	19.56%	-	-	0.92%
Professional Services	9.56M	9.27M	-	9.37M	9.8M
Professional Services Growth	-	-3.07%	-	-	4.60%
Software Contribution	-	1M	-	1.8M	8.02M
Software Contribution Growth	-	-	-	-	345.33%
Drug Discovery Contribution	-	-	1.95M	-	-
Drug Discovery Contribution Growth	-	-	-	-	-
Revenue From Contract With Customer Before Contribution	91.53M	-	-	-	-
Revenue From Contract With Customer Before Contribution Growth	-	-	-	-	-
Contribution	1M	-	-	-	-
Contribution Growth	-	-	-	-	-

Revenue by Geography

	2020	2021	2022	2023	2024
UNITED STATES	60.74M	90.4M	123.56M	161.96M	114.87M
UNITED STATES Growth	-	48.84%	36.68%	31.08%	-29.08%
EMEA	-	-	-	29.14M	65.65M
EMEA Growth	-	-	-	-	125.33%
APAC	-	-	-	24.57M	25.8M
APAC Growth	-	-	-	-	5.02%
Non-US	-	-	13.88M	1M	1.22M
Non-US Growth	-	-	-	-92.79%	21.68%
Europe	24.37M	27.81M	33.05M	-	-
Europe Growth	-	14.12%	18.84%	-	-
JAPAN	14.56M	8.56M	10.47M	-	-
JAPAN Growth	-	-41.17%	22.23%	-	-
Non Us	8.43M	11.16M	-	-	-
Non Us Growth	-	32.36%	-	-	-

Frequently Asked Questions

Growth & Financials

Schrödinger, Inc. (SDGR) reported $257.0M in revenue for fiscal year 2024. This represents a 361% increase from $55.7M in 2017.

Schrödinger, Inc. (SDGR) saw revenue decline by 4.2% over the past year.

Schrödinger, Inc. (SDGR) reported a net loss of $176.0M for fiscal year 2024.

Dividend & Returns

Schrödinger, Inc. (SDGR) has a return on equity (ROE) of -38.6%. Negative ROE indicates the company is unprofitable.

Schrödinger, Inc. (SDGR) had negative free cash flow of $3.4M in fiscal year 2024, likely due to heavy capital investments.

US Stock Screener

...

Schrödinger, Inc. (SDGR) 10-Year Financial Performance & Capital Metrics

SDGR • • Industrial / General

HealthcareHealthcare ITLife Sciences TechnologyDrug Discovery & Development

Revenue $208M -4.2%
EBITDA -$203M -18.2%
Net Income -$187M -559.5%
EPS (Diluted) -2.57 -575.9%
Gross Margin 63.64% -2.0%
EBITDA Margin -97.88% -23.4%
Operating Margin -100.85% -23.1%
Net Margin -90.16% -579.7%
ROE -38.58% -572.1%
ROIC -34.38% -28.5%
Debt/Equity 0.28 +19.9%
Interest Coverage -

Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

✓Strong 5Y sales CAGR of 19.4%
✓Share count reduced 3.1% through buybacks

✗Weaknesses

✗Weak Piotroski F-Score: 3/9
✗Negative free cash flow
✗Trading more than 30% below 52-week high
✗Low asset turnover indicates capital-intensive operations

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y-

5Y19.39%

3Y14.59%

TTM32.9%

Profit (Net Income) CAGR

10Y-

5Y-

3Y-

TTM0.89%

EPS CAGR

10Y-

5Y-

3Y-

TTM1.63%

ROCE

10Y Avg-30.43%

5Y Avg-23.28%

3Y Avg-28.06%

Latest-32.18%

Peer Comparison

Drug Discovery & Development

Name	Market Cap	Current Price	P/E Ratio	Revenue Growth 1Y	Net Margin	ROE	FCF Yield	Debt/Equity
SLPSimulations Plus, Inc.	408.17M	20.26	-6.29	13.09%	-81.66%	-50.54%	4.27%	0.00
SDGRSchrödinger, Inc.	1.13B	17.47	-6.80	-4.21%	-68.49%	-54.77%		0.28
CERTCertara, Inc.	1.52B	9.52	-126.76	8.7%	2.62%	1.02%	5.2%	0.29

Profit & Loss

	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Sales/Revenue+	55.69M	66.64M	85.54M	108.09M	137.93M	180.96M	216.67M	207.54M
Revenue Growth %	-	0.2%	0.28%	0.26%	0.28%	0.31%	0.2%	-0.04%
Cost of Goods Sold+	15.89M	23.7M	36.45M	44.62M	72.31M	79.93M	75.97M	75.46M
COGS % of Revenue	0.29%	0.36%	0.43%	0.41%	0.52%	0.44%	0.35%	0.36%
Gross Profit+	39.8M	42.94M	49.09M	63.47M	65.62M	101.02M	140.69M	132.08M
Gross Margin %	0.71%	0.64%	0.57%	0.59%	0.48%	0.56%	0.65%	0.64%
Gross Profit Growth %	-	0.08%	0.14%	0.29%	0.03%	0.54%	0.39%	-0.06%
Operating Expenses+	58.82M	70.91M	87.81M	124.39M	177.06M	247.84M	318.14M	341.38M
OpEx % of Revenue	1.06%	1.06%	1.03%	1.15%	1.28%	1.37%	1.47%	1.64%
Selling, General & Admin	31.15M	36.38M	48.4M	59.69M	86.16M	121.47M	136.37M	139.59M
SG&A % of Revenue	0.56%	0.55%	0.57%	0.55%	0.62%	0.67%	0.63%	0.67%
Research & Development	27.67M	34.52M	39.4M	64.69M	90.9M	126.37M	181.77M	201.78M
R&D % of Revenue	0.5%	0.52%	0.46%	0.6%	0.66%	0.7%	0.84%	0.97%
Other Operating Expenses	0	0	0	0	0	0	0	0
Operating Income+	-19.02M	-27.97M	-38.72M	-60.92M	-111.44M	-146.82M	-177.45M	-209.3M
Operating Margin %	-0.34%	-0.42%	-0.45%	-0.56%	-0.81%	-0.81%	-0.82%	-1.01%
Operating Income Growth %	-	-0.47%	-0.38%	-0.57%	-0.83%	-0.32%	-0.21%	-0.18%
EBITDA+	-17.34M	-25.07M	-35.08M	-57.26M	-108.6M	-142.47M	-171.9M	-203.14M
EBITDA Margin %	-0.31%	-0.38%	-0.41%	-0.53%	-0.79%	-0.79%	-0.79%	-0.98%
EBITDA Growth %	-	-0.45%	-0.4%	-0.63%	-0.9%	-0.31%	-0.21%	-0.18%
D&A (Non-Cash Add-back)	1.69M	2.89M	3.64M	3.66M	2.85M	4.34M	5.55M	6.16M
EBIT	-19.02M	-27.97M	-38.72M	-60.92M	-111.44M	-146.82M	-177.45M	-209.3M
Net Interest Income+	359K	433K	1.88M	2.25M	1.06M	3.95M	0	0
Interest Income	359K	433K	1.88M	2.25M	1.06M	3.95M	0	0
Interest Expense	0	0	0	0	0	3K	0	0
Other Income/Expense	1.96M	-379K	12.74M	34.62M	10.63M	-2.31M	220.37M	23.59M
Pretax Income+	-17.06M	-28.35M	-25.97M	-26.29M	-100.81M	-149.12M	42.92M	-185.71M
Pretax Margin %	-0.31%	-0.43%	-0.3%	-0.24%	-0.73%	-0.82%	0.2%	-0.89%
Income Tax+	332K	77K	-291K	345K	411K	63K	2.2M	1.41M
Effective Tax Rate %	1.02%	1%	0.95%	0.93%	1%	1%	0.95%	1.01%
Net Income+	-17.39M	-28.43M	-24.57M	-24.46M	-100.39M	-149.19M	40.72M	-187.12M
Net Margin %	-0.31%	-0.43%	-0.29%	-0.23%	-0.73%	-0.82%	0.19%	-0.9%
Net Income Growth %	-	-0.63%	0.14%	0%	-3.1%	-0.49%	1.27%	-5.6%
Net Income (Continuing)	-17.39M	-28.43M	-25.68M	-26.64M	-101.22M	-149.19M	40.72M	-187.12M
Discontinued Operations	0	0	0	0	0	0	0	0
Minority Interest	0	0	41K	4K	14K	11K	0	0
EPS (Diluted)+	-3.07	-0.59	-0.41	-0.44	-1.43	-2.10	0.54	-2.57
EPS Growth %	-	0.81%	0.31%	-0.07%	-2.25%	-0.47%	1.26%	-5.76%
EPS (Basic)	-3.07	-0.59	-0.41	-0.44	-1.43	-2.10	0.57	-2.57
Diluted Shares Outstanding	5.67M	48.47M	63.27M	60.02M	70.59M	71.17M	74.99M	72.67M
Basic Shares Outstanding	5.67M	48.47M	63.27M	60.02M	70.59M	71.17M	71.78M	72.67M
Dividend Payout Ratio	-	-	-	-	-	-	-	-

Balance Sheet

	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Current Assets+	48.05M	104.69M	118.54M	682.98M	625.06M	533.99M	567.8M	634.99M
Cash & Short-Term Investments	36.34M	84.07M	85.83M	642.69M	576.48M	451.09M	463M	352.12M
Cash Only	9.96M	77.72M	25.99M	202.3M	120.27M	90.47M	155.31M	147.33M
Short-Term Investments	26.38M	6.35M	59.84M	440.39M	456.21M	360.61M	307.69M	204.8M
Accounts Receivable	9.76M	18.02M	25.74M	35.38M	40.55M	69.09M	89.12M	255.33M
Days Sales Outstanding	63.96	98.71	109.82	119.46	107.31	139.36	150.13	449.06
Inventory	0	0	0	0	0	0	0	0
Days Inventory Outstanding	-	-	-	-	-	-	-	-
Other Current Assets	0	0	500K	500K	3M	5.24M	5.75M	15.33M
Total Non-Current Assets+	9.97M	16.04M	36.73M	63.28M	131.43M	154.6M	235.16M	188.23M
Property, Plant & Equipment	5.44M	7.97M	19.03M	15.27M	85.41M	120.23M	141.1M	136.08M
Fixed Asset Turnover	10.24x	8.36x	4.50x	7.08x	1.61x	1.51x	1.54x	1.53x
Goodwill	0	0	0	0	0	4.79M	4.79M	4.79M
Intangible Assets	52K	15K	0	0	0	587K	0	0
Long-Term Investments	2.61M	5.44M	15.37M	45.66M	43.17M	25.68M	83.25M	43.21M
Other Non-Current Assets	1.87M	2.61M	2.34M	2.35M	2.85M	3.31M	6.01M	4.16M
Total Assets+	58.02M	120.73M	155.27M	746.26M	756.49M	688.59M	802.96M	823.23M
Asset Turnover	0.96x	0.55x	0.55x	0.14x	0.18x	0.26x	0.27x	0.25x
Asset Growth %	-	1.08%	0.29%	3.81%	0.01%	-0.09%	0.17%	0.03%
Total Current Liabilities+	17.82M	27M	45.02M	73.2M	91.21M	108.8M	133.67M	191.75M
Accounts Payable	1.61M	2.77M	3.52M	8.4M	8.08M	9.47M	16.82M	10.67M
Days Payables Outstanding	36.98	42.7	35.29	68.69	40.78	43.24	80.78	51.59
Short-Term Debt	0	0	0	0	0	0	0	0
Deferred Revenue (Current)	1000K	1000K	1000K	1000K	1000K	1000K	1000K	1000K
Other Current Liabilities	2.41M	0	0	0	0	0	0	0
Current Ratio	2.70x	3.88x	2.63x	9.33x	6.85x	4.91x	4.25x	3.31x
Quick Ratio	2.70x	3.88x	2.63x	9.33x	6.85x	4.91x	4.25x	3.31x
Cash Conversion Cycle	-	-	-	-	-	-	-	-
Total Non-Current Liabilities+	85.57M	165.28M	203.57M	49.04M	108.19M	131.88M	120.72M	210.03M
Long-Term Debt	0	0	0	0	0	0	0	0
Capital Lease Obligations	0	0	8.89M	7.22M	77.83M	105.48M	111.01M	101.07M
Deferred Tax Liabilities	0	0	0	0	0	0	0	0
Other Non-Current Liabilities	82.79M	162.17M	192.48M	654K	300K	800K	667K	146K
Total Liabilities	103.38M	192.29M	248.59M	122.24M	199.4M	240.68M	254.4M	401.78M
Total Debt+	0	0	14.47M	11.76M	79.87M	116.49M	127.88M	117.83M
Net Debt	-9.96M	-77.72M	-11.51M	-190.53M	-40.4M	26.02M	-27.43M	-29.5M
Debt / Equity	-	-	-	0.02x	0.14x	0.26x	0.23x	0.28x
Debt / EBITDA	-	-	-	-	-	-	-	-
Net Debt / EBITDA	-	-	-	-	-	-	-	-
Interest Coverage	-	-	-	-	-	-48939.00x	-	-
Total Equity+	-45.36M	-71.56M	-93.32M	624.02M	557.09M	447.9M	548.56M	421.44M
Equity Growth %	-	-0.58%	-0.3%	7.69%	-0.11%	-0.2%	0.22%	-0.23%
Book Value per Share	-8.00	-1.48	-1.48	10.40	7.89	6.29	7.32	5.80
Total Shareholders' Equity	-45.36M	-71.56M	-93.36M	624.01M	557.07M	447.89M	548.56M	421.44M
Common Stock	55K	59K	61K	699K	710K	714K	722K	729K
Retained Earnings	-52.1M	-80.53M	-105.1M	-129.56M	-229.95M	-379.14M	-338.42M	-525.54M
Treasury Stock	-6.36M	-8.53M	0	0	0	0	0	0
Accumulated OCI	-27K	-9K	16K	317K	-651K	-2.38M	281K	220K
Minority Interest	0	0	41K	4K	14K	11K	0	0

Cash Flow

	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Cash from Operations+	-15.31M	-23.71M	-26.06M	16.76M	-70.67M	-119.68M	-136.73M	-157.37M
Operating CF Margin %	-0.27%	-0.36%	-0.3%	0.16%	-0.51%	-0.66%	-0.63%	-0.76%
Operating CF Growth %	-	-0.55%	-0.1%	1.64%	-5.22%	-0.69%	-0.14%	-0.15%
Net Income	-17.39M	-28.43M	-25.68M	-26.64M	-101.22M	-149.19M	40.72M	-187.12M
Depreciation & Amortization	1.69M	2.89M	3.64M	3.66M	2.85M	4.34M	5.55M	6.16M
Stock-Based Compensation	888K	1.31M	2.19M	10.54M	26.49M	39.63M	47.84M	49.9M
Deferred Taxes	-2.1M	375K	0	-32.12M	0	0	0	0
Other Non-Cash Items	19K	-149K	-10.51M	2.14M	-3.46M	6.91M	-208.29M	-13.27M
Working Capital Changes	1.59M	281K	4.29M	59.18M	4.68M	-21.38M	-22.55M	-13.04M
Change in Receivables	-3.1M	-4.27M	-6.59M	-12.75M	-5.51M	-27.95M	-20.03M	-166.22M
Change in Inventory	2.65M	-3.86M	0	7.34M	0	0	0	0
Change in Payables	45K	969K	-294K	4.88M	-411K	1.18M	7.32M	-6.12M
Cash from Investing+	2.05M	11.19M	-53.85M	-381.72M	-16.81M	90.02M	193.03M	148.84M
Capital Expenditures	-3.7M	-5.26M	-1.84M	-2.54M	-7.17M	-8.01M	-13.4M	-7.31M
CapEx % of Revenue	0.07%	0.08%	0.02%	0.02%	0.05%	0.04%	0.06%	0.04%
Acquisitions	-	-	-	-	-	-	-	-
Investments	-	-	-	-	-	-	-	-
Other Investing	3.24M	-3.65M	943K	4.58M	375K	11.82M	147.21M	0
Cash from Financing+	1.13M	80.27M	28.68M	541.27M	7.95M	2.11M	9.05M	10.12M
Debt Issued (Net)	-	-	-	-	-	-	-	-
Equity Issued (Net)	-	-	-	-	-	-	-	-
Dividends Paid	0	0	0	0	0	0	0	0
Share Repurchases	-	-	-	-	-	-	-	-
Other Financing	0	80.27M	-1.21M	4.18M	7.95M	2.11M	9.07M	1.31M
Net Change in Cash	-	-	-	-	-	-	-	-
Free Cash Flow+	-19.01M	-28.97M	-27.89M	14.22M	-77.84M	-127.7M	-150.14M	-164.68M
FCF Margin %	-0.34%	-0.43%	-0.33%	0.13%	-0.56%	-0.71%	-0.69%	-0.79%
FCF Growth %	-	-0.52%	0.04%	1.51%	-6.47%	-0.64%	-0.18%	-0.1%
FCF per Share	-3.35	-0.60	-0.44	0.24	-1.10	-1.79	-2.00	-2.27
FCF Conversion (FCF/Net Income)	0.88x	0.83x	1.06x	-0.68x	0.70x	0.80x	-3.36x	0.84x
Interest Paid	0	0	0	0	0	0	0	0
Taxes Paid	348K	13K	139K	381K	448K	787K	2.83M	1.08M

Key Ratios

Metric	2017	2018	2019	2020	2021	2022	2023	2024
Return on Equity (ROE)	-	-	-	-9.22%	-17%	-29.69%	8.17%	-38.58%
Return on Invested Capital (ROIC)	-	-	-	-27.8%	-17.59%	-22.23%	-26.75%	-34.38%
Gross Margin	71.46%	64.43%	57.39%	58.72%	47.57%	55.83%	64.94%	63.64%
Net Margin	-31.23%	-42.66%	-28.72%	-22.63%	-72.78%	-82.44%	18.79%	-90.16%
Debt / Equity	-	-	-	0.02x	0.14x	0.26x	0.23x	0.28x
Interest Coverage	-	-	-	-	-	-48939.00x	-	-
FCF Conversion	0.88x	0.83x	1.06x	-0.68x	0.70x	0.80x	-3.36x	0.84x
Revenue Growth	-	19.65%	28.37%	26.36%	27.6%	31.19%	19.73%	-4.21%

Revenue by Segment

	2020	2021	2022	2023	2024
Software Products And Services	92.53M	113.24M	-	159.12M	180.37M
Software Products And Services Growth	-	22.38%	-	-	13.35%
Revenue From Contract With Customer Before Software Contribution	-	112.24M	-	157.32M	172.35M
Revenue From Contract With Customer Before Software Contribution Growth	-	-	-	-	9.55%
On Premise Software	58.31M	74.6M	-	104.51M	104.02M
On Premise Software Growth	-	27.93%	-	-	-0.47%
Hosted Software	9.19M	11.08M	-	20.38M	35.25M
Hosted Software Growth	-	20.50%	-	-	72.97%
Maintenance	14.46M	17.29M	-	23.07M	23.28M
Maintenance Growth	-	19.56%	-	-	0.92%
Professional Services	9.56M	9.27M	-	9.37M	9.8M
Professional Services Growth	-	-3.07%	-	-	4.60%
Software Contribution	-	1M	-	1.8M	8.02M
Software Contribution Growth	-	-	-	-	345.33%
Drug Discovery Contribution	-	-	1.95M	-	-
Drug Discovery Contribution Growth	-	-	-	-	-
Revenue From Contract With Customer Before Contribution	91.53M	-	-	-	-
Revenue From Contract With Customer Before Contribution Growth	-	-	-	-	-
Contribution	1M	-	-	-	-
Contribution Growth	-	-	-	-	-

Revenue by Geography

	2020	2021	2022	2023	2024
UNITED STATES	60.74M	90.4M	123.56M	161.96M	114.87M
UNITED STATES Growth	-	48.84%	36.68%	31.08%	-29.08%
EMEA	-	-	-	29.14M	65.65M
EMEA Growth	-	-	-	-	125.33%
APAC	-	-	-	24.57M	25.8M
APAC Growth	-	-	-	-	5.02%
Non-US	-	-	13.88M	1M	1.22M
Non-US Growth	-	-	-	-92.79%	21.68%
Europe	24.37M	27.81M	33.05M	-	-
Europe Growth	-	14.12%	18.84%	-	-
JAPAN	14.56M	8.56M	10.47M	-	-
JAPAN Growth	-	-41.17%	22.23%	-	-
Non Us	8.43M	11.16M	-	-	-
Non Us Growth	-	32.36%	-	-	-

Frequently Asked Questions

Growth & Financials

Schrödinger, Inc. (SDGR) reported $257.0M in revenue for fiscal year 2024. This represents a 361% increase from $55.7M in 2017.

Schrödinger, Inc. (SDGR) saw revenue decline by 4.2% over the past year.

Schrödinger, Inc. (SDGR) reported a net loss of $176.0M for fiscal year 2024.

Dividend & Returns

Schrödinger, Inc. (SDGR) has a return on equity (ROE) of -38.6%. Negative ROE indicates the company is unprofitable.

Schrödinger, Inc. (SDGR) had negative free cash flow of $3.4M in fiscal year 2024, likely due to heavy capital investments.